埼玉医科大学雑誌 第33巻 第3, 4号 (2006年12月) 41-45頁 ◇論文(図表を含む全文)は,PDFファイルとなっています.

PDF (1.6 MB)

原 著
埼玉医科大学病院における前立腺癌に対する高線量率組織内照射の経験

黒田 功1),塚本 拓司1),中平 洋子1),矢内原 仁1),吉村 一良1),上野 宗久1),出口 修宏1),内野 三菜子2),関根 広2),土器屋 卓志2)
1) 埼玉医科大学泌尿器科 2) 埼玉医科大学放射線腫瘍科
〔平成18年11月24日 受付〕


HDR Brachytherapy for Prostate Cancer at Saitama Medical University : A Preliminary Report
1)KURODA Isao, 1)TSUKAMOTO Takuji, 1)NAKAHIRA Youko, 1)YANAIHARA Hitoshi, 1)YOSHIMURA Ichirou, 1)UENO Munehisa, 1)DEGUCHI Nobuhiro, 2)UCHINO Minako, 2)SEKINE Hiroshi, 2)DOKIYA Takushi (Department of Urology1), Department of Radiology2), Saitama Medical University, Moroyama, Iruma-gun, Saitama 350-0495, Japan)

 We started radical radiotherapy for prostatic carcinoma since October 2003 besides surgical prostatectomy. The modality of radiotherapy was high dose rate brachytherapy(HDR) with external beam radiation therapy(EBRT). Assessment of the outcomes of HDR with EBRT was compared with that of retropubic radical prostatectomy (RRP) by serum PSA measurement after 6 months of the treatment. Curative ratio of HDR with EBRT and RRP were 79.5% and 62%, respectively. Definitely the efficacy of radiotherapy for prostatic carcinoma was equal to that of surgical therapy.
Keywords: prostate cancer, brachytherapy, HDR
J Saitama Medical University 2006;33:41-45
(Received November 24, 2006)


(C) 2006 The Medical Society of Saitama Medical School